Contraception
Volume 64, Issue 4 , Pages 227-234 , October 2001

On the mechanisms of action of short-term levonorgestrel administration in emergency contraception

  • Marta Durand

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
    • ,
  • Ma del Carmen Cravioto

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
    • ,
  • Elizabeth G Raymond

      Affiliations

    • Family Health International, Research Triangle Park, NC, USA
    • ,
  • Ofelia Durán-Sánchez

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
    • ,
  • Ma De la Luz Cruz-Hinojosa

      Affiliations

    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
    • ,
  • Andrés Castell-Rodrı́guez

      Affiliations

    • Department of Cellular Biology, School of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico
    • ,
  • Raffaela Schiavon

      Affiliations

    • Reproductive Health Service, Instituto Nacional de Pediatrı́a, Mexico City, Mexico
    • ,
  • Fernando Larrea

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +525-573-11-60; fax: +525-655-98-59
    • Department of Reproductive Biology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

References 

  1. Stanczyk FZ, Roy S. Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids. Contraception. 1990;42:67–96
  2. Edgren RA, Smith H, Hughes GA, et al.  Biological effects of racemic and resolved 13β-ethyl-4gonen-3-ones. Steroids. 1963;2:731
  3. Coukell AJ, Balfour JA. Levonorgestrel subdermal implants. A review of contraceptive efficacy, and acceptability. Drugs. 1998;55:861–887
  4. Glassier A. Emergency postcoital contraception. N Engl J Med. 1997;337:1058–1064
  5. World Health Organization. Task Force on Postovulatory Methods of Fertility Regulation . Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined contraceptives for emergency contraception. Lancet. 1998;352:428–433
  6. Ling WY, Robichaud A, Zayid Y, Wrixon W, MacLeod SC. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. Fertil Steril. 1979;32:297–302
  7. Ling WY, Wrixon W, Zayid Y, Acorn T, Popat R, Wilson E. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. II. Effects of postovulatory administration on ovarian function and endometrium. Fertil Steril. 1983;39:292–297
  8. Ling WY, Wrixon W, Acorn T, Wilson E, Collins J. Mode of action of dl-norgestrel and ethinylestradiol combination in postcoital contraception. III. Effects of preovulatory administration following the luteinizing hormone surge on ovarian steroidogenesis. Fertil Steril. 1983;40:631–636
  9. Swahn ML, Westlund P, Johannisson E, Bygdeman M. Effect of post-coital contraceptive methods on the endometrium, and the menstrual cycle. Acta Obstet Gynecol Scand. 1996;75:738–744
  10. Kesserü E, Garmendia F, Westphal N, Parada J. The hormonal, and peripheral effects of d-norgestrel in postcoital contraception. Contraception. 1974;10:411–424
  11. Ugocsai G, Resch B, Traub A, Sas M. Biological, microscopic, and scanning electron microscopic investigations of the effects of Postinor/d-norgestrel in rabbits. Contraception. 1984;30:153–159
  12. Landgren BM, Johannisson E, Aedo AR, Kumar A, Yong-en S. The effects of levonorgestrel administered in large doses at different stages of the cycle on ovarian function, and endometrial morphology. Contraception. 1989;39:275–289
  13. Spona J, Matt K, Schneider WHF. Study on the action of d-norgestrel as a postcoital contraceptive agent. Contraception. 1975;11:31–43
  14. Garmendia F, Kesserü E, Urdanivia E, Valencia M. Luteinizing hormone, and progesterone in women under postcoital contraception with d-norgestrel. Fertil Steril. 1976;27:1250–1255
  15. Wilcox AJ, Weinberg CR, Baird DD. Timing the sexual intercourse in relation to ovulation. N Engl J Med. 1995;333:1517–1521
  16. Batzer FR. Ultrasonic indices of ovulation. J Reprod Med. 1986;31(Suppl):764–769
  17. Harper MJK. The implantation window. Baillieres Clin Obstet Gynaecol. 1992;6:351–371
  18. Yaron Y, Botchan A, Amit A, Peyser MR, David MP, Lessing JB. Endometrial receptivity in the light of modern assisted reproductive technologies. Fertil Steril. 1994;62:225–232
  19. Miller PB, Soules MR. The usefulness of a urinary LH kit for ovulation prediction during menstrual cycles of normal women. Obstet Gynecol. 1996;87:13–17
  20. Larrea F, Sandoval JL, Salinas E, Franco-Rodrı́guez A, Méndez I, Ulloa-Aguirre A. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia. Clin Endocrinol. 1995;43:591–600
  21. Hernández I, Parra A, Méndez I, et al.  Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome. Arch Med Res. 2000;31:216–222
  22. Johannisson E, Landgren BM, Rohr HP, Diczfalusy E. Endometrial morphology, and peripheral hormone levels in women with regular menstrual cycles. Fertil Steril. 1987;48:401–408
  23. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–25
  24. Hendrickson MR, Kempson RL. Normal histology of the uterus and fallopian tubes. In:  Sternberg SS editors. Histology for pathologist. Philadelphia-New York: Lippincott-Raven; 1997;p. 879–927
  25. Lessey BA, Castelbaum AJ, Wolf L, et al.  Use of integrins to date the endometrium. Fertil Steril. 2000;73:779–787
  26. Peters AJ, Wentz AC. Endometrial receptivity and the luteal phase. Curr Opin Obstet Gynecol. 1992;4:736–742
  27. Gaddum J. Lognormal distributions. Nature. 1945;156:463–466
  28. Bolton S. Statistical inference (estimation, and hypothesis testing). In:  Swarbrick J editors. Pharmaceutical statistics (practical, and clinical applications). New York: Marcel Dekker Inc; 1990;p. 146–157
  29. Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod. 1993;8:389–392
  30. Moggia A, Beauquis A, Ferrari F, et al.  The use of progestogens as postcoital contraceptives. J Reprod Med. 1974;13:58–61
  31. Kesserü E, Camacho-Ortega P, Laudahn G, Schopflin G. In vitro actions of progestogens on sperm migration in human cervical mucus. Fertil Steril. 1975;26:57–61
  32. Seregély G. Results of a multicentric trial of Postinor. Ther Hung. 1982;30:72–78
  33. Manikkam M, Rajamahendran R. Progesterone-induced atresia of the proestrous dominant follicle in the bovine ovary (changes in diameter, insulin-like growth factor system, aromatase activity, steroid hormones, and apoptotic index). Biol Reprod. 1997;57:580–587
  34. Schreiber J, Nakamura K, Erickson G. Progestins inhibit FSH-stimulated steroidogenesis in cultured rat granulosa cells. Mol Cell Endocrinol. 1980;19:165–173
  35. Fortune J, Vincent S. Progestrone inhibits the induction of aromatase activity in rat granulosa cells in vitro. Biol Reprod. 1983;28:1078–1089
  36. Goodman A, Hodgen G. Antifolliculogenic action of progesterone despite hypersecretion of FSH in monkeys. Am J Physiol. 1982;243:E387–E397
  37. Wiebe H, Morris C. Effect on an oral contraceptive on adrenal, and ovarian androgenic steroids. Obstet Gynecol. 1984;63:12–14
  38. Odell WD, Swederdloff RS. Progesterone-induced luteinizing and follicle-stimulating hormone surge in postmenopausal women (a stimulated ovulatory peak). Proc Natl Acad Sci USA. 1968;61:529–536
  39. Aono T, Miyake A, Kunigasa T, Kurachi K. Progesterone advancement of estrogen-induced luteinizing hormone release during the midfollicular phase in normal cyclic women. J Endocrinol. 1976;71:451–452
  40. Hoff JD, Quigley ME, Yen SSC. Hormonal dynamics at midcycle (a re-evaluation). J Clin Endocrinol Metab. 1983;57:792–796
  41. Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Merriam GR, Loriaux DL. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge, and ovulation. J Clin Endocrinol Metab. 1992;74:565–570
  42. Soules M, Steiner R, Clifton D, Cohen N, Aksel S, Bremner W. Progesterone modulation of pulsatile luteinizing hormone secretion in women. J Clin Endocrinol Metab. 1984;58:378–383
  43. Von Hertzen H. Research on new methods of emergency contraception. J Reprod Med. 1996;5:12–18
  44. Lydon JP, DeMayo FJ, Funk CR, et al.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 1995;9:2266–2278
  45. Okada Y, Asahina T, Kobayashi T, Goto J, Terao T. Studies on the mechanism of edematous changes at the endometrial stroma for implantation. Semin Thromb Hemost. 2001;27:67–77
  46. Craven CM, Morgan T, Ward K. Decidual spiral artery remodeling begins before cellular interaction with cytotrophoblasts. Placenta. 1998;19:241–252
  47. Blankenship TN, Enders AC. Trophoblast cell-mediated modifications to uterine spiral arteries during early gestation in the macaque. Acta Anat. 1997;158:227–236
  48. Raymond EG, Lovely LP, Chen-Mok M, Seppälä M, Kurman RJ, Lessey BA. Effect of the Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod. 2000;15:2351–2355

☆ This study was supported by grants from Family Health International (North Carolina, USA), US Agency for International Development (Washington, DC, USA), the Andrew W. Mellon Foundation (New York, USA), and El Consejo Nacional de Ciencia y Tecnologı́a (Mexico).

PII: S0010-7824(01)00250-5

Contraception
Volume 64, Issue 4 , Pages 227-234 , October 2001

Article Tools

* Image Usage & Resolution